Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 1:49 AM UTC
| NCT Number | NCT06772623 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 252 participants |
| Active Locations | 27 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT06772623 is currently recruiting participants. This phase1 study for lung cancer is actively seeking new participants at 27 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06772623 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06772623 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.